Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
Conditions:   Parathyroid Carcinoma;   Primary Hyperparathyroidism Intervention:   Drug: KHK7580 Sponsor:   Kyowa Hakko Kirin Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2017 Category: Research Source Type: clinical trials

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
Conditions:   Parathyroid Carcinoma;   Primary Hyperparathyroidism Intervention:   Drug: KHK7580 Sponsor:   Kyowa Hakko Kirin Co., Ltd Recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2017 Category: Research Source Type: clinical trials

Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior
Conditions:   Parathyroid Carcinoma;   Parathyroid Neoplasm Intervention:   Other: Chart Review Sponsor:   M.D. Anderson Cancer Center Recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2017 Category: Research Source Type: clinical trials